GW Pharmaceuticals PLC is defying stigmas with strong clinical results for its cannabinoid Epidiolex in rare forms of pediatric epilepsy, announcing a second round of successful clinical trial results just three months after the first set.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?